This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pernix Therapeutics Holdings Inc (PTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents n.a. n.a. n.a. n.a.
Receivables n.a. n.a. n.a. n.a.
Inventories n.a. n.a. n.a. n.a.
Other Current Assets n.a. n.a. n.a. n.a.
Total Current Assets n.a. n.a. n.a. n.a.
Property, Plant & Equipment, Gross n.a. n.a. n.a. n.a.
Accumulated Depreciation & Depletion n.a. n.a. n.a. n.a.
Property, Plant & Equipment, Net n.a. n.a. n.a. n.a.
Intangibles 340.81M 345.39M 122.52M 141.22M
Other Non-Current Assets 170.35M 142.02M 88.87M 110.23M
Total Non-Current Assets 511.16M 487.41M 211.39M 251.45M
Liabilities & Shareholder Equity
Total Assets 511.16M 487.41M 211.39M 251.45M
Accounts Payable n.a. n.a. n.a. n.a.
Short Term Debt 0.00 7.34M 17.00M 2.29M
Other Current Liabilities n.a. n.a. n.a. n.a.
Total Current Liabilities n.a. n.a. n.a. n.a.
Long Term Debt 313.75M 285.00M 1.31M 41.35M
Deferred Income Taxes n.a. n.a. n.a. n.a.
Other Non-Current Liabilities 164.31M 111.48M 82.35M 129.27M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 478.06M 396.48M 83.66M 170.62M
Total Liabilities 478.06M 403.82M 100.66M 172.91M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 33.10M 83.59M 110.72M 78.54M
Common Par 611.00K 383.00K 371.89K 296.03K
Additional Paid In Capital 226.84M 129.13M 119.55M 58.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -188.80M -40.49M -5.20M 20.43M
Treasury Stock -5.55M -5.43M -4.00M -3.77M
Other Equity Adjustments 0.00 0.00 0.00 2.98M
Total Capitalization n.a. n.a. n.a. n.a.
Total Equity 33.10M 83.59M 110.72M 78.54M
Total Liabilities & Stock Equity 511.16M 487.41M 211.39M 251.45M
Total Common Shares Outstanding 61.11M 38.34M 37.19M 34.03M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.76M 2.46M 2.13M 2.07M
Basic Weighted Shares Outstanding 53.32M 37.87M 36.44M 28.15M
Diluted Weighted Shares Outstanding 53.32M 37.87M 36.44M 28.15M
Number of Employees 274 155 191 251
Number of Part-Time Employees 0 0 0 0
PTX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PTX Pernix Therapeutics Holdings Inc

Chart of PTX

Analysts Ratings for PTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 3 3
Moderate Buy 0 0 0 0
Hold 2 2 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PTX ANALYST REPORT

PTX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs